Line 34: |
Line 34: |
| ==Additional Information== | | ==Additional Information== |
| | | |
− | *''ANKRD26 (OMIM: 610855)'' has been associated with thrombocytopenia 2 ([https://www.omim.org/entry/188000 OMIM: 188000)] | + | *''ANKRD26 (OMIM: [https://omim.org/entry/610855 610855])'' has been associated with thrombocytopenia 2 (OMIM: [https://www.omim.org/entry/188000 188000]) |
− | *''CEBPA (OMIM: 116897)'' has been associated with acute myeloid leukemia ([https://www.omim.org/entry/601626 OMIM: 601626)] | + | *''CEBPA (OMIM: [https://omim.org/entry/116897 116897])'' has been associated with acute myeloid leukemia (OMIM: [https://www.omim.org/entry/601626 601626]) |
− | *''DDX41'' ''(OMIM: 608170)'' has been associated with susceptibility to multiple types of familial myeloproliferative/lymphoproliferative neoplasms (OMIM: 616871, <nowiki>https://www.omim.org/entry/616871</nowiki>). | + | *''DDX41'' ''(OMIM: 608170)'' has been associated with susceptibility to multiple types of familial myeloproliferative/lymphoproliferative neoplasms (OMIM: [https://www.omim.org/entry/616871 616871]) |
− | *''ETV6'' ''(OMIM: 600618)'' has been associated with thrombocytopenia 5 (OMIM: 616216, <nowiki>https://www.omim.org/entry/616216</nowiki>). | + | *''ETV6'' ''(OMIM: [https://omim.org/entry/600618 600618])'' has been associated with thrombocytopenia 5 (OMIM: [https://www.omim.org/entry/616216 616216]) |
− | *''GATA2 (OMIM: 137295)'' has been associated with susceptibility to acute myeloid leukemia (OMIM: 601626, <nowiki>https://www.omim.org/entry/601626</nowiki>). | + | *''GATA2 (OMIM: [https://omim.org/entry/137295 137295])'' has been associated with susceptibility to acute myeloid leukemia (OMIM: [https://www.omim.org/entry/601626 601626]) |
− | *''RUNX1'' ''(OMIM: 151385)'' has been associated with acute myeloid leukemia (OMIM: 601626) and familial platelet disorder with associated myeloid malignancy (OMIM: 601399, <nowiki>https://www.omim.org/entry/601399</nowiki>). | + | *''RUNX1'' ''(OMIM: [https://omim.org/entry/151385 151385])'' has been associated with acute myeloid leukemia (OMIM: [https://www.omim.org/entry/601626 601626]) and familial platelet disorder with associated myeloid malignancy (OMIM: [https://www.omim.org/entry/601399 601399]) |
− | *''DDX41'' ''(OMIM: 608170)'' has been associated with susceptibility to multiple types of familial myeloproliferative/lymphoproliferative neoplasms (OMIM: 616871, <nowiki>https://www.omim.org/entry/616871</nowiki>).
| + | *''SAMD9'' ''(OMIM: 610456)'' has been associated with Myelodysplasia, Infection, Restriction of growth, Adrenal hypoplasia, Genital phenotypes, and Enteropathy (MIRAGE syndrome, (OMIM: 617053) , <nowiki>https://www.omim.org/entry/617053</nowiki>). |
− | *''SAMD9'' ''(OMIM: 610456)'' has been associated with Myelodysplasia, Infection, Restriction of growth, Adrenal hypoplasia, Genital phenotypes, and Enteropathy (MIRAGE syndrome, OMIM: 617053, <nowiki>https://www.omim.org/entry/617053</nowiki>). | + | *''SAMD9L'' ''(OMIM: 611170)'' has been associated with ataxia-pancytopenia syndrome, or myelocerebellar disorder, ataxia-pancytopenia syndrome (OMIM: 159550) , <nowiki>https://www.omim.org/entry/159550</nowiki>). |
− | *''SAMD9L'' ''(OMIM: 611170)'' has been associated with ataxia-pancytopenia syndrome, or myelocerebellar disorder, ataxia-pancytopenia syndrome (OMIM: 159550, <nowiki>https://www.omim.org/entry/159550</nowiki>). | + | *''SRP72'' ''(OMIM: 602122)'' has been associated with bone marrow failure syndrome 1 (OMIM: 614675) , <nowiki>https://www.omim.org/entry/614675</nowiki>). |
− | *''SRP72'' ''(OMIM: 602122)'' has been associated with bone marrow failure syndrome 1 (OMIM: 614675, <nowiki>https://www.omim.org/entry/614675</nowiki>). | + | *''TP53'' ''(OMIM: 191170)'' has been associated with Li-Fraumeni syndrome (OMIM: 151623) , <nowiki>https://www.omim.org/entry/151623</nowiki>). |
− | *''TP53'' ''(OMIM: 191170)'' has been associated with Li-Fraumeni syndrome (OMIM: 151623, <nowiki>https://www.omim.org/entry/151623</nowiki>). | + | *''BLM'' ''(OMIM: 604610)'' has been associated with Bloom syndrome (OMIM: 210900) , <nowiki>https://www.omim.org/entry/210900</nowiki>). |
− | *''BLM'' ''(OMIM: 604610)'' has been associated with Bloom syndrome (OMIM: 210900, <nowiki>https://www.omim.org/entry/210900</nowiki>). | + | *Constitutional mismatch repair deficiency (OMIM: 276300) , <nowiki>https://www.omim.org/entry/276300</nowiki>) |
− | *Constitutional mismatch repair deficiency (OMIM: 276300, <nowiki>https://www.omim.org/entry/276300</nowiki>) | + | *Neurofibromatosis type I (NF1, OMIM: 162200) , <nowiki>https://www.omim.org/entry/162200</nowiki>) |
− | *Neurofibromatosis type I (NF1, OMIM: 162200, <nowiki>https://www.omim.org/entry/162200</nowiki>) | + | *Nijmegen breakage syndrome (NBS, OMIM: 251260) , <nowiki>https://www.omim.org/entry/251260</nowiki>) |
− | *Nijmegen breakage syndrome (NBS, OMIM: 251260, <nowiki>https://www.omim.org/entry/251260</nowiki>) | + | *Noonan syndrome (please see Genetic heterogeneity of Noonan syndrome at OMIM: 163950) <nowiki>https://www.omim.org/entry/163950</nowiki> |
− | *Noonan syndrome (please see Genetic heterogeneity of Noonan syndrome at <nowiki>https://www.omim.org/entry/163950</nowiki> | + | *Fanconi anemia (FA, please see Genetic heterogeneity of Fanconi anemia at OMIM: 227650) <nowiki>https://www.omim.org/entry/227650</nowiki>), |
− | *Fanconi anemia (FA, please see Genetic heterogeneity of Fanconi anemia at <nowiki>https://www.omim.org/entry/227650</nowiki>), | + | *Dyskeratosis congenital (DC, please see Genetic heterogeneity of dyskeratosis congenital at OMIM: 127550) <nowiki>https://www.omim.org/entry/127550</nowiki>). |
− | *Dyskeratosis congenital (DC, please see Genetic heterogeneity of dyskeratosis congenital at <nowiki>https://www.omim.org/entry/127550</nowiki>). | + | *Severe congenital neutropenia (SCN, please see Genetic heterogeneity of severe congenital neutropenia at OMIM; 202700) <nowiki>https://www.omim.org/entry/202700</nowiki>) |
− | *Severe congenital neutropenia (SCN, please see Genetic heterogeneity of severe congenital neutropenia at <nowiki>https://www.omim.org/entry/202700</nowiki>) | + | *Shwachman-Diamond syndrome 1 (SDS1, OMIM: 260400) , <nowiki>https://www.omim.org/entry/260400</nowiki>) and Shwachman-Diamond syndrome 2 (SDS2, OMIM: 617941) , <nowiki>https://www.omim.org/entry/617941</nowiki>) |
− | *Shwachman-Diamond syndrome 1 (SDS1, OMIM: 260400, <nowiki>https://www.omim.org/entry/260400</nowiki>) and Shwachman-Diamond syndrome 2 (SDS2, OMIM: 617941, <nowiki>https://www.omim.org/entry/617941</nowiki>) | + | *Diamond Blackfan anemia (DBA, please see Genetic heterogeneity of Diamond Blackfan anemia at OMIM: 105650) <nowiki>https://www.omim.org/entry/105650</nowiki>). |
− | *Diamond Blackfan anemia (DBA, please see Genetic heterogeneity of Diamond Blackfan anemia at <nowiki>https://www.omim.org/entry/105650</nowiki>). | |
| | | |
| ==References== | | ==References== |